VERICEL CORPORATION - COMMON STOCK

Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults

29 ديسمبر 2022 12:45:00 بحسب Nasdaq GlobeNewswire

Vericel to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Service Forum and the Stephens Annual Investment Conference

10 نوفمبر 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Vericel Reports Third Quarter 2022 Financial Results

09 نوفمبر 2022 06:55:00 بحسب Nasdaq GlobeNewswire

Vericel to Report Third-Quarter 2022 Financial Results on November 9, 2022

26 أكتوبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Vericel to Present at the Ladenburg Thalmann Healthcare Conference

22 سبتمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Vericel to Present at the Morgan Stanley Global Healthcare and H.C. Wainwright Global Investment Conferences

06 سبتمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Vericel Reports Second Quarter 2022 Financial Results

03 أغسطس 2022 06:55:00 بحسب Nasdaq GlobeNewswire

Vericel Announces Publication of Positive Results from Retrospective Study by the Burn and Reconstructive Centers of America (BRCA) of Patients with Large Posterior Trunk Burns Treated with Epicel

21 يوليو 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Vericel to Report Second-Quarter 2022 Financial Results on August 3, 2022

20 يوليو 2022 07:30:01 بحسب Nasdaq GlobeNewswire

Vericel Reports First Quarter 2022 Financial Results

04 مايو 2022 06:55:00 بحسب Nasdaq GlobeNewswire

Vericel to Report First-Quarter 2022 Financial Results on May 4, 2022

20 أبريل 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022

15 مارس 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Vericel to Present at the Cowen 42nd Annual Health Care Conference on March 9, 2022

01 مارس 2022 07:30:01 بحسب Nasdaq GlobeNewswire

Vericel Announces Appointment of Jonathan Siegal as Principal Accounting Officer

24 فبراير 2022 15:45:00 بحسب Nasdaq GlobeNewswire

Vericel Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Full-Year 2022 Financial Guidance

24 فبراير 2022 06:55:00 بحسب Nasdaq GlobeNewswire

Vericel to Report Fourth-Quarter 2021 Financial Results on February 24, 2022

10 فبراير 2022 08:00:01 بحسب Nasdaq GlobeNewswire

Vericel Announces Plans for a New State-of-the-Art Cell Therapy Manufacturing Facility to Support Long-Term Growth

02 فبراير 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Vericel to Present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022

04 يناير 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Vericel to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on November 18th, 2021

11 نوفمبر 2021 07:30:00 بحسب Nasdaq GlobeNewswire

Vericel Reports Third Quarter 2021 Financial Results

09 نوفمبر 2021 06:40:00 بحسب Nasdaq GlobeNewswire